Wulandari Bangun Laksana Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Wulandari Bangun Laksana Tbk trades at Rp52 (market cap 1.3T, 8.31M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Wulandari Bangun Laksana Tbk is far larger — about 4.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Wulandari Bangun Laksana Tbk is more actively traded (8.31M versus 963.6K). Which is the better fit depends on your goals.
| BSBK | DGNS | |
|---|---|---|
Market Cap | 1.3T | 310.75B |
Volume | 8.31M | 963.6K |
Lot | 83.09K | 9.64K |
Turnover | 424.91M | 217.67M |
Average Price | 51.14 | 225.89 |
Value | 424.91M | 217.67M |
Indicative Equilibrium Price | 52 | 226 |
Indicative Equilibrium Volume | 3.32K | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Wulandari Bangun Laksana Tbk (the “Company”) was established under the name PT Dwipagrya Lestari in Jakarta based on Deed No. 21 dated September 7, 1994 by Linda Ibrahim, S.H., Notary in Jakarta. The Company commended its commercial operations on 2005.
Read more on BSBK →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →